TP2204L |
CCK Octapeptide, non-sulfated acetate
|
TP2204L
|
98%
|
|
CCK Octapeptide, non-sulfated acetate is a synthetic desulfated peptide of cholecystokinin.
|
T9991 |
WAY-620645
|
742116-45-6
|
98%
|
|
WAY-620645 is a CCK antagonist with antitumor and analgesic activities.
|
T27503 |
GV150013
|
167355-22-8
|
98%
|
|
GV150013 is an antagonist of cholecystokinin-2 (CCK2) receptor.
|
T27503L |
GV-150013X
|
151386-96-8
|
98%
|
|
GV-150013X is a potent CCKB antiagonist, pKi= 9.02.
|
T15382 |
GI 181771
|
305366-98-7
|
98%
|
|
GI 181771 is an agonist of the cholecystokinin 1 receptor. GI 181771 can be used in studies about obesity.
|
T14932 |
Ceruletide
|
17650-98-5
|
98%
|
|
Ceruletide is a potent agonist of cholecystokinin receptor and it also is a safe and effective cholecystokinetic agent. It has a direct spasmogenic effect on the...
|
TP1931L1 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate
|
TP1931L1
|
98%
|
|
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin...
|
T68016 |
Spiroglumide
|
137795-35-8
|
98%
|
|
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be ...
|
T15759 |
Lintitript
|
136381-85-6
|
98%
|
|
Lintitript is a selective antagonist of CCK1 with EC50s of 6 nM and 200 nM for CCK1 and CCK2. The Ki value is 0.2 nM for CCK1.
|
TP2030L1 |
Gastrin I (human) acetate
|
TP2030L1
|
98%
|
|
Gastrin I (human) acetate is the endogenous peptide produced in the stomach, and increases gastric acid secretion via cholecystokinin 2 (CCK2) receptor.
|
T9343 |
N-Cbz-DL-tryptophan
|
13058-16-7
|
98%
|
|
N-Cbz-DL-tryptophan is a cholecystokinin receptor antagonist, abolished the response of the isolated heart to CCK-8.
|
T11868 |
Lorglumide sodium salt
|
1021868-76-7
|
98%
|
|
Lorglumide sodium salt is an antagonist of cholecystokinin receptors (CCK).
|
T6206 |
PHA-767491
|
845714-00-3
|
98%
|
|
PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.
|
T1052 |
Proglumide
|
6620-60-6
|
98%
|
|
Proglumide is a cholecystokinin antagonist, which blocks both the CCKA and CCKB subtypes. Proglumide is a drug that exerts an inhibitory effect on gastric secret...
|
T4579 |
Pentagastrin
|
5534-95-2
|
98%
|
|
pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally, which can cause the secretion and synthesis of salivary proteins.
|
TQ0062 |
Nastorazepide
|
209219-38-5
|
98%
|
|
Nastorazepide (Z-360) is a selective, orally available antagonist of gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity.
|
T14932L |
Ceruletide Ammonium acetate
|
T14932L
|
98%
|
|
Ceruletide Ammonium acetate is a cholecystokinin (CCK) receptor agonist. Ceruletide Ammonium acetate is a safe and effective cholecystokinetic agent and small bo...
|
T2312 |
Loxiglumide
|
107097-80-3
|
98%
|
|
Loxiglumide is an antagonist of cholecystokinin (CCK-1) receptor.
|
T6735 |
XL413 hydrochloride
|
2062200-97-7
|
98%
|
|
XL413 (BMS-863233) hydrochloride is a potent, selective and ATP competitive inhibitor of Cdc7, with an IC 50 of 3.4 nM. XL413 (BMS-863233) hydrochloride also exh...
|
TP1821L |
Mini Gastrin I, human acetate
|
TP1821L
|
98%
|
|
Mini Gastrin I, human acetate is a shorter version of human gastrin, consists of amino acids 5-17 of the parent peptide.
|